JP2016508503A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016508503A5 JP2016508503A5 JP2015556154A JP2015556154A JP2016508503A5 JP 2016508503 A5 JP2016508503 A5 JP 2016508503A5 JP 2015556154 A JP2015556154 A JP 2015556154A JP 2015556154 A JP2015556154 A JP 2015556154A JP 2016508503 A5 JP2016508503 A5 JP 2016508503A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- seq
- amino acids
- fusion protein
- rsv
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108020001507 fusion proteins Proteins 0.000 claims description 23
- 102000037865 fusion proteins Human genes 0.000 claims description 23
- 150000001413 amino acids Chemical class 0.000 claims description 20
- 108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 claims description 14
- 239000012634 fragment Substances 0.000 claims description 10
- 229940124158 Protease/peptidase inhibitor Drugs 0.000 claims description 8
- 239000000137 peptide hydrolase inhibitor Substances 0.000 claims description 8
- 239000000427 antigen Substances 0.000 claims description 6
- 102000036639 antigens Human genes 0.000 claims description 6
- 108091007433 antigens Proteins 0.000 claims description 6
- 230000004927 fusion Effects 0.000 claims description 6
- 102000040430 polynucleotide Human genes 0.000 claims description 6
- 108091033319 polynucleotide Proteins 0.000 claims description 6
- 239000002157 polynucleotide Substances 0.000 claims description 6
- 102000004169 proteins and genes Human genes 0.000 claims description 6
- 108090000623 proteins and genes Proteins 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 5
- 101710132601 Capsid protein Proteins 0.000 claims description 4
- 101710094648 Coat protein Proteins 0.000 claims description 4
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 claims description 4
- 241000711920 Human orthopneumovirus Species 0.000 claims description 4
- 101710125418 Major capsid protein Proteins 0.000 claims description 4
- 101710141454 Nucleoprotein Proteins 0.000 claims description 4
- 101710083689 Probable capsid protein Proteins 0.000 claims description 4
- 239000000203 mixture Substances 0.000 claims description 3
- 235000000832 Ayote Nutrition 0.000 claims description 2
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 2
- 240000001980 Cucurbita pepo Species 0.000 claims description 2
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 2
- 241000725643 Respiratory syncytial virus Species 0.000 claims description 2
- 101710112927 Trypsin inhibitor 2 Proteins 0.000 claims description 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 2
- 238000004925 denaturation Methods 0.000 claims description 2
- 230000036425 denaturation Effects 0.000 claims description 2
- 239000013604 expression vector Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 230000002163 immunogen Effects 0.000 claims description 2
- 239000003112 inhibitor Substances 0.000 claims description 2
- 230000007774 longterm Effects 0.000 claims description 2
- 229920001184 polypeptide Polymers 0.000 claims description 2
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 2
- 235000015136 pumpkin Nutrition 0.000 claims description 2
- 238000012216 screening Methods 0.000 claims description 2
- 239000013598 vector Substances 0.000 claims description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 241000218991 Ecballium Species 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361759664P | 2013-02-01 | 2013-02-01 | |
| US61/759,664 | 2013-02-01 | ||
| US201361783380P | 2013-03-14 | 2013-03-14 | |
| US61/783,380 | 2013-03-14 | ||
| PCT/US2014/014054 WO2014121021A1 (en) | 2013-02-01 | 2014-01-31 | Respiratory syncytial virus f protein epitopes |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016508503A JP2016508503A (ja) | 2016-03-22 |
| JP2016508503A5 true JP2016508503A5 (enExample) | 2017-02-23 |
| JP6450688B2 JP6450688B2 (ja) | 2019-01-09 |
Family
ID=51262966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015556154A Active JP6450688B2 (ja) | 2013-02-01 | 2014-01-31 | 呼吸器合胞体ウイルスｆタンパク質エピトープ |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US10016496B2 (enExample) |
| EP (1) | EP2950886B1 (enExample) |
| JP (1) | JP6450688B2 (enExample) |
| CN (1) | CN105073196B (enExample) |
| AU (1) | AU2014212268B2 (enExample) |
| CA (1) | CA2900110A1 (enExample) |
| CY (1) | CY1122937T1 (enExample) |
| DK (1) | DK2950886T3 (enExample) |
| ES (1) | ES2778899T3 (enExample) |
| HR (1) | HRP20200404T1 (enExample) |
| LT (1) | LT2950886T (enExample) |
| PL (1) | PL2950886T3 (enExample) |
| PT (1) | PT2950886T (enExample) |
| RS (1) | RS60056B1 (enExample) |
| SI (1) | SI2950886T1 (enExample) |
| SM (1) | SMT202000145T1 (enExample) |
| WO (1) | WO2014121021A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| TWI659968B (zh) | 2013-03-14 | 2019-05-21 | 再生元醫藥公司 | 針對呼吸道融合病毒ｆ蛋白質的人類抗體及其使用方法 |
| SI3094353T1 (sl) | 2014-01-15 | 2020-07-31 | Medimmune, Llc | RSY-specifična protitelesa in njihovi funkcionalni deli |
| JO3555B1 (ar) | 2015-10-29 | 2020-07-05 | Merck Sharp & Dohme | جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري |
| US11479600B2 (en) | 2016-10-21 | 2022-10-25 | Adimab, Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| EP3974447A3 (en) * | 2016-10-21 | 2022-09-07 | Adimab, LLC | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| SG11201903287PA (en) | 2016-10-21 | 2019-05-30 | Adimab Llc | Anti-respiratory syncytial virus antibodies, and methods of their generation and use |
| TWI683826B (zh) * | 2016-11-22 | 2020-02-01 | 國立臺灣大學 | 重組ｒｓｖ抗原 |
| TW202228779A (zh) | 2017-03-01 | 2022-08-01 | 英商梅迪繆思有限公司 | 抗rsv單株抗體配製物 |
| US12024553B2 (en) | 2019-04-30 | 2024-07-02 | Medimmune Limited | Dosage regimens for and compositions including anti-RSV antibodies |
| CN111208307B (zh) * | 2020-04-21 | 2020-07-17 | 上海普铭生物科技有限公司 | 一种与参照分子具有相同或不同的靶蛋白结合的分子的筛选方法 |
| CN119462859A (zh) * | 2023-08-09 | 2025-02-18 | 深圳瑞吉生物科技有限公司 | 呼吸道合胞病毒抗原性多肽、疫苗及其应用 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US20020018780A1 (en) * | 2000-05-25 | 2002-02-14 | Scott Koenig | Epitope-based vaccine for respiratory syncytial virus F-protein |
| EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
| SG190562A1 (en) | 2008-04-18 | 2013-06-28 | Vaxinnate Corp | Deletion mutants of flagellin and methods of use |
| CA2755257A1 (en) | 2009-03-16 | 2010-09-23 | Sanofi Pasteur Biologics Co. | Replication-defective flavivirus vaccine vectors against respiratory syncytial virus |
| CA2776249C (en) | 2009-10-06 | 2021-01-19 | Medimmune Ltd | Rsv-specific binding molecule |
| US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
| WO2011056899A2 (en) | 2009-11-03 | 2011-05-12 | Ligocyte Pharmaceuticals, Inc. | Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps |
| WO2012089231A1 (en) * | 2010-12-30 | 2012-07-05 | Okairòs Ag | Paramyxovirus vaccines |
| US9738689B2 (en) | 2013-03-13 | 2017-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion RSV F proteins and their use |
| SMT202400297T1 (it) | 2013-03-13 | 2024-09-16 | The United States Of America As Represented By The Secretary Department Of Health And Human Services | Proteine f del rsv pre-fusione e loro uso |
| US9060975B2 (en) | 2013-03-14 | 2015-06-23 | Mucosis Bv | Heat-stable respiratory syncytial virus F protein oligomers and their use in immunological compositions |
-
2014
- 2014-01-31 DK DK14746750.0T patent/DK2950886T3/da active
- 2014-01-31 ES ES14746750T patent/ES2778899T3/es active Active
- 2014-01-31 JP JP2015556154A patent/JP6450688B2/ja active Active
- 2014-01-31 CA CA2900110A patent/CA2900110A1/en not_active Abandoned
- 2014-01-31 AU AU2014212268A patent/AU2014212268B2/en active Active
- 2014-01-31 US US14/764,635 patent/US10016496B2/en active Active
- 2014-01-31 SI SI201431530T patent/SI2950886T1/sl unknown
- 2014-01-31 HR HRP20200404TT patent/HRP20200404T1/hr unknown
- 2014-01-31 EP EP14746750.0A patent/EP2950886B1/en active Active
- 2014-01-31 WO PCT/US2014/014054 patent/WO2014121021A1/en not_active Ceased
- 2014-01-31 CN CN201480007046.4A patent/CN105073196B/zh active Active
- 2014-01-31 SM SM20200145T patent/SMT202000145T1/it unknown
- 2014-01-31 PL PL14746750T patent/PL2950886T3/pl unknown
- 2014-01-31 RS RS20200305A patent/RS60056B1/sr unknown
- 2014-01-31 PT PT147467500T patent/PT2950886T/pt unknown
- 2014-01-31 LT LTEP14746750.0T patent/LT2950886T/lt unknown
-
2020
- 2020-03-18 CY CY20201100248T patent/CY1122937T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016508503A5 (enExample) | ||
| JP2019519216A5 (enExample) | ||
| JP2020055849A5 (enExample) | ||
| JP2019524645A5 (enExample) | ||
| JP2018033454A5 (enExample) | ||
| JP2016026215A5 (enExample) | ||
| JP2018023398A5 (enExample) | ||
| JP2016063812A5 (enExample) | ||
| IL288541B (en) | Vaccine against rsv | |
| HRP20200404T1 (hr) | Epitopi proteina f respiratornog sincijalnog virusa | |
| JP2015212284A5 (enExample) | ||
| JP2017518072A5 (enExample) | ||
| JP2018198596A5 (enExample) | ||
| JP2005120106A5 (enExample) | ||
| JP2017048194A5 (enExample) | ||
| JP2019531055A5 (enExample) | ||
| JP2017514522A5 (enExample) | ||
| JP2016515114A5 (enExample) | ||
| JP2011528901A5 (enExample) | ||
| JP2014237714A5 (enExample) | ||
| JP2020501532A5 (enExample) | ||
| JP2017512063A5 (enExample) | ||
| JP2010521147A5 (enExample) | ||
| JP2014518883A5 (enExample) | ||
| CA2953714C (en) | Anti-tnfa antibodies with ph-dependent antigen binding |